ArticleCurrent research in toxicology2026
Assessment of a novel heated non-tobacco product versus the 1R6F reference cigarette: A comparative study.
Article in Current research in toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heated tobacco products (HTPs) have emerged as a new option for smokers seeking alternatives to cigarettes. Tobacco Heating System (THS) 3.0 consists of an induction heating device that heats specially designed tobacco sticks (i.e., HTPs) or heated non-tobacco products (HnTPs), without triggering combustion. HnTPs are tobacco-free and consist of a cellulose-based substrate with nicotine salt, aerosol former, and flavors. This study assessed the chemical composition, physical properties, cytotoxicity, genotoxicity, and mutagenicity of HnTP aerosol in comparison with cigarette smoke. The absence of tobacco and combustion results in substantially reduced amount of harmful and potentially harmful constituents (HPHCs) in the HnTP aerosol compared to cigarette smoke. Characterization of the aerosol demonstrated that HPHCs are reduced on average by at least 99% compared to cigarette smoke, and the aerosol is liquid-based, further distinguishing it from combustion-derived particulate matter. Non-targeted differential screening analysis did not identify any new compounds of toxicological concern compared to cigarette smoke. In vitro studies with a battery of tests, including neutral red uptake, micronucleus, and Ames assay, demonstrated that aerosol fractions of HnTP, when used together with THS 3.0 device, induced substantially less cytotoxicity, mutagenicity, and genotoxicity responses than cigarette smoke. Collectively, the evidence demonstrates that HnTP used as part of the induction heating system does not involve combustion and results in substantially fewer and lower levels of HPHCs, leading to reduced in vitro toxicity compared to cigarette smoke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.